Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

First came the slow hand movements, then the tremor, and now the looming fear of what lies ahead. By the end of the decade, ...

Michael J. Fox made an appearance over the weekend at the Fan Expo in New Orleans, alongside his cast members from the Back ...

The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Michael Vick is coming back home to the Chesapeake ... The legendary former quarterback currently serves as a co-host for FOX's NFL Sunday studio show, and Vick's fellow co-hosts signaled their ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

ASAP is now accepting Letters of Intent for the Collaborative Research Network 2025 Scientific Track. This new call is centered around dissecting the mechanisms that can contribute to Parkinson's ...

Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.

Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms appear, leading to new diagnostic tools and disease-modi ...